The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries
Open accessAbstract
Background: Hypertension is the leading preventable cause of premature death worldwide. We examined global disparities of hypertension prevalence, awareness, treatment, and control in 2010 and compared secular changes from 2000 to 2010. Methods: We searched MEDLINE from 1995 through 2014 and supplemented with manual searches of retrieved article references. We included 135 population-based studies of 968 419 adults from 90 countries. Sex- and age-specific hypertension prevalences from each country were applied to population data to calculate regional and global numbers of hypertensive adults. Proportions of awareness, treatment, and control from each country were applied to hypertensive populations to obtain regional and global estimates. Results: In 2010, 31.1% (95% confidence interval, 30.0%–32.2%) of the world’s adults had hypertension; 28.5% (27.3%–29.7%) in high-income countries and 31.5% (30.2%–32.9%) in low- and middle-income countries. An estimated 1.39 (1.34–1.44) billion people had hypertension in 2010: 349 (337–361) million in high-income countries and 1.04 (0.99–1.09) billion in low- and middle-income countries. From 2000 to 2010, the age-standardized prevalence of hypertension decreased by 2.6% in high-income countries, but increased by 7.7% in low- and middle-income countries. During the same period, the proportions of awareness (58.2% versus 67.0%), treatment (44.5% versus 55.6%), and control (17.9% versus 28.4%) increased substantially in high-income countries, whereas awareness (32.3% versus 37.9%) and treatment (24.9% versus 29.0%) increased less, and control (8.4% versus 7.7%) even slightly decreased in low- and middle-income countries. Conclusions: Global hypertension disparities are large and increasing. Collaborative efforts are urgently needed to combat the emerging hypertension burden in low- and middle-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite several initiatives, the prevalence of raised BP and adverse impact on cardiovascular morbidity and mortality are increasing globally, irrespective of income. 4,5”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When reviewing global figures, an estimated 1.39 billion people had hypertension in 2010. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The large disparities in the regional burden of hypertension are accompanied by low levels of awareness, treatment and control rates in LMIC, when compared to HIC.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“with an estimated 349 million with hypertension in HIC and 1.04 billion in LMICs. 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“In response to poor global awareness for hypertension (estimated 67% in HIC and 38% in LMIC), 4”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“good BP control was only achieved in less than one-third and one-tenth of patients with hypertension in highincome and lower-income countries, respectively. 4”
In the citing paper
“About 1/4th of adults have high blood pressure”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Between 1.13 and 1.4 billion people had hypertension in 2010 (defined as >140/90 mm Hg.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Worldwide, about half of adults with hypertension are unaware that their blood pressure is high, a situation more dire in low-income countries.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“Two-thirds of those living with hypertension are in low- and middle-income countries where most of the world's population lives”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
In the citing paper
“In high-income countries, the average rates of awareness, treatment, and control are 67%, 55.6%, and 28.4%, respectively, while in low- to middle-income countries the rates are 37.9%, 29%, and 7.7%, respectively.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citationForouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Global burden of blood-pressure-related disease, 2001
Lawes, C. M. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,314
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 1,006
Feleke, Y., Yadeta, D., Geletew, T. K., Gelibo, T., Getachew, T., Lemu, K. A., Challa, F., Mengesha, A. B., Degefu, F. S., Defar, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194819 · Cited by 145
Yu, Z., Coresh, J., Qi, G., Grams, M., Boerwinkle, E., Snieder, H., Teumer, A., Pattaro, C., Köttgen, A., Chatterjee, N., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.044 · Cited by 135
Clinical inertia in the pharmacological management of hypertension
Milman, T., Joundi, R. A., Alotaibi, N. M., & Saposnik, G. (2018) · Medicine · doi:10.1097/md.0000000000011121 · Cited by 143
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
Ojangba, T., Boamah, S., Miao, Y., Guo, X., Fen, Y., Agboyibor, C., Yuan, J., & Dong, W. (2023) · The Journal of Clinical Hypertension · doi:10.1111/jch.14653 · Cited by 136
The role of inflammation in hypertension: novel concepts
Patrick, D. M., Beusecum, J. P. V., & Kirabo, A. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.09.016 · Cited by 140
“Despite these improvements, there remainssignificantdisparities inhypertension control globally, with low income countries exhibiting increases in prevalence and poorer control of hypertension [73].”
Lim, H. B., Lee, M. W., Park, J., Kim, K., Jo, Y. J., & Kim, J. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.11.016 · Cited by 133
Chowdhury, M. Z. I., Rahman, M. M., Akter, T., Akhter, T., Ahmed, A., Shovon, M. A., Farhana, Z., Chowdhury, N. A., & Turin, T. C. (2020) · Clinical Hypertension · doi:10.1186/s40885-020-00143-1 · Cited by 143
World Heart Federation Roadmap for Hypertension – A 2021 Update
Jeemon, P., Séverin, T., Amodeo, C., Balabanova, D., Campbell, N. R. C., Gaiță, D. I., Kario, K., Khan, T., Melifonwu, R., Moran, A. E., et al. (2021) · Global Heart · doi:10.5334/gh.1066 · Cited by 153
Valensi, P. E. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01356-w · Cited by 145
Dzau, V. J., & Hodgkinson, C. P. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21710 · Cited by 155
Hypertension Assessment via ECG and PPG Signals: An Evaluation Using MIMIC Database
Liang, Y., Chen, Z., Ward, R. K., & Elgendi, M. (2018) · Diagnostics · doi:10.3390/diagnostics8030065 · Cited by 132
“04 billion people had hypertension in LMICs in 2010 [40].”
BackgroundBeddhu, S., Greene, T., Boucher, R., Cushman, W. C., Wei, G., Stoddard, G., Ix, J. H., Chonchol, M., Kramer, H., Cheung, A. K., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30099-8 · Cited by 128
Dai, H., Bragazzi, N. L., Younis, A., Zhong, W., Liu, X., Wu, J., & Grossman, E. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16483 · Cited by 129
Two-Drug Combinations as First-Step Antihypertensive Treatment
Mancia, G., Rea, F., Corrao, G., & Grassi, G. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313294 · Cited by 130
Lamelas, P. M., Díaz, R., Orlandini, A., Avezum, Á., Oliveira, G. B. F., Mattos, A. J. C., Lanas, F. T., Pamela Serón, S., Oliveros, M. J., López-Jaramillo, P. A., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002108 · Cited by 128
“This is consistent with prior assessments and prediction of HTN prevalence by other studies, including Latin America [28,29].”
ResultYeoh, E., Wong, M. C. S., Wong, E. L., Yam, C. H. K., Poon, C. M., Chung, R. Y., Chong, K. C., Fang, Y., Wang, H., Liang, M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.057 · Cited by 128
Townsend, R. R., Walton, A., Hettrick, D. A., Hickey, G. L., Weil, J., Sharp, A. S. P., Blankenstijn, P. J., Böhm, M., & Mancia, G. (2020) · EuroIntervention · doi:10.4244/eij-d-19-00902 · Cited by 129
Mahfoud, F., Schmieder, R. E., Azizi, M., Pathak, A., Sievert, H., Tsioufis, C. P., Zeller, T., Bertog, S. C., Blankestijn, P. J., Böhm, M., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx215 · Cited by 124
Stroke in Women: A Review Focused on Epidemiology, Risk Factors, and Outcomes
Yoon, C. W., & Bushnell, C. (2023) · Journal of Stroke · doi:10.5853/jos.2022.03468 · Cited by 141
Alfaro, F. J., Gavrieli, A., Saade-Lemus, P., Lioutas, V., Upadhyay, J., & Novak, V. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.009 · Cited by 125
Global health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
Niebauer, J., Börjesson, M., Carré, F., Caselli, S., Palatini, P., Quattrini, F. M., Serratosa, L., Adami, P. E., Biffi, A., Preßler, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy511 · Cited by 121
“Arterial hypertension is the most relevant risk factor for cardiovascular disease worldwide and one of the most common abnormalities identified during clinical evaluation of athletes.(1) The European Society of Cardiology (ESC) guidelines advocate regular physical activity as a Class IA recommendation for the preventi…”
Husain, M. J., Datta, B. K., Kostova, D., Joseph, K. T., Asma, S., Richter, P., Jaffe, M. G., & Kishore, S. P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015302 · Cited by 121
Li, Q., Qie, R., Qin, P., Zhang, D., Guo, C., Zhou, Q., Tian, G., Liu, D., Chen, X., Liu, L., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.033 · Cited by 120
Beddhu, S., Rocco, M. V., Toto, R. D., Craven, T. E., Greene, T., Bhatt, U. Y., Cheung, A. K., Cohen, D. L., Freedman, B. I., Hawfield, A. T., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2966 · Cited by 120
Salt, Hypertension, and Immunity
Rucker, A. J., Rudemiller, N. P., & Crowley, S. D. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121134 · Cited by 123
Effect of alcohol on blood pressure
Tasnim, S., Tang, C., Musini, V. M., & Wright, J. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012787.pub2 · Cited by 136
Beutel, M. E., Brähler, E., Ernst, M., Klein, E., Reiner, I., Wiltink, J., Michal, M., Wild, P. S., Schulz, A., Münzel, T. F., et al. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckaa015 · Cited by 117
Silveira‐Nunes, G., Durso, D. F., Júnior, L. R. A. D. O., Cunha, E. H. M., Maioli, T. U., Vieira, A. T., Speziali, E., Corrêa‐Oliveira, R., Martins‐Filho, O. A., Teixeira‐Carvalho, A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00258 · Cited by 121
The role of macrophages in hypertension and its complications
Rucker, A. J., & Crowley, S. D. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1950-x · Cited by 118
The antihypertensive potential of flavonoids from Chinese Herbal Medicine: A review
Cao, Y. L., Xie, L., Liu, K., Liang, Y., Dai, X., Wang, X., Lu, J., Zhang, X., & Li, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105919 · Cited by 116
Shu, H., Cheng, J. R., Li, N., Zhang, Z., Nie, J., Peng, Y., Wang, Y., Wang, D. W., & Zhou, N. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01913-5 · Cited by 115
Renin-angiotensin system at the heart of COVID-19 pandemic
Alifano, M., Alifano, P., Forgez, P., & Iannelli, A. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.008 · Cited by 114
“7% of patients in low- andmiddleincome countries [25].”
Effects of isometric resistance training on resting blood pressure
Smart, N. A., Way, D., Carlson, D. J., Millar, P. J., McGowan, C. L. M., Swaine, I., Baross, A., Howden, R., Ritti‐Dias, R. M., Wiles, J. D., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002105 · Cited by 119
“Given that approximately 50% of people with hypertension do not have their blood pressure successfully controlled to within clinical targets [9], prevention and treatment of hypertension are now global priorities of the WHO [10].”
BackgroundInsomnia and the risk of hypertension: A meta-analysis of prospective cohort studies
Li, L., Gan, Y., Zhou, X., Jiang, H., Zhao, Y., Tian, Q., He, Y. L., Liu, Q., Mei, Q., Wu, C., et al. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101403 · Cited by 124
Nawi, A. M., Mohammad, Z., Jetly, K., Razak, M. A. A., Ramli, N. S., Ibadullah, W. A. H. W., & Ahmad, N. (2021) · International Journal of Hypertension · doi:10.1155/2021/6657003 · Cited by 141
Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?
Barrows, I. R., Ramezani, A., & Raj, D. S. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.03.001 · Cited by 116
The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension
Xiu, J., Lin, X., Chen, Q., Yu, P., Lü, J., Yang, Y., Chen, W., Bao, K., Wang, J., Zhu, J., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1163900 · Cited by 119
Hypertension and NAFLD risk: Insights from the NHANES 2017–2018 and Mendelian randomization analyses
Yuan, M., He, J., Hu, X., Yao, L., Chen, P., Wang, Z., Liu, P., Xiong, Z., Jiang, Y., & Li, L. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002753 · Cited by 113
“[4] It is worth noting that a cross-sectional multicenter study found that compared to normotensive youth, hypertensive youth had an increased body mass Association for the Study of Liver (EASL), Diabetes (EASD), and Obesity (EASO) recommend that non-alcoholic steatohepatitis patients with fibrosis…”
ResultSelf-citationPadwal, R., Campbell, N. R. C., Schutte, A. E., Olsen, M. H., Delles, C., Etyang, A., Cruickshank, J. K., Stergiou, G., Rakotz, M. K., Wozniak, G., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002112 · Cited by 108
“4 billion [2], could lead to the incorrect classification of hypertension status in 84 million individuals worldwide.”
BackgroundInfluentialFrieden, T. R., & Jaffe, M. G. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13195 · Cited by 117
Dziedziak, J., Zaleska-Żmijewska, A., Szaflik, J. P., & Cudnoch‐Jędrzejewska, A. (2022) · Medical Science Monitor · doi:10.12659/msm.935135 · Cited by 109
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Wu, Y., Xu, H., Tu, X., & Gao, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.730809 · Cited by 117
Cheung, C. Y.-L., Biousse, V., Keane, P. A., Schiffrin, E. L., & Wong, T. Y. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00342-0 · Cited by 116
Bundy, J. D., Mills, K. T., Chen, J., Li, C., Greenland, P., & He, J. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1240 · Cited by 109
Self-citationWhelton, P. K., & Williams, B. (2018) · JAMA · doi:10.1001/jama.2018.16755 · Cited by 108
Mahfoud, F., Renkin, J. P., Sievert, H., Bertog, S. C., Ewen, S., Böhm, M., Lengelé, J., Wojakowski, W., Schmieder, R. E., van der Giet, M., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.10.048 · Cited by 105
Three Public Health Interventions Could Save 94 Million Lives in 25 Years
Kontis, V., Cobb, L. K., Mathers, C. D., Frieden, T. R., Ezzati, M., & Danaei, G. (2019) · Circulation · doi:10.1161/circulationaha.118.038160 · Cited by 104
“6) 76 (69, 82) Micronesia (Federated States of) 1 (1, 1) 4.”
InfluentialZou, Y., Zhong, L., Hu, C., & Sheng, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01419-z · Cited by 106
The lncRNA TUG1/miR-145-5p/FGF10 regulates proliferation and migration in VSMCs of hypertension
Shi, L., Tian, C., Sun, L., Cao, F., & Meng, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.049 · Cited by 103
Qin, P., Luo, X., Zeng, Y., Zhang, Y., Li, Y., Wu, Y., Han, M., Qie, R., Wu, X., Liu, D., et al. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.148620 · Cited by 106
Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism
Vorselaars, W. M. C. M., Nell, S., Postma, E. L., Zarnegar, R., Drake, F. T., Duh, Q., Talutis, S. D., McAneny, D. B., McManus, C. M., Lee, J. A., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.5842 · Cited by 101
Schoettker, P., Degott, J., Hofmann, G., Proença, M., Bonnier, G., Lemkaddem, A., Lemay, M., Schorer, R., Christen, U., Knebel, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74955-4 · Cited by 102
John, O., Campbell, N. R. C., Brady, T. M., Farrell, M., Varghese, C. V., Berumen, A. V., Gaitán, L. A. U., Toffelmire, N., Ameel, M., Mideksa, M., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16625 · Cited by 100
Melo, R. G. E., Mourão, M., Caldeira, D., Alves, M., Lopes, A. D. M., Duarte, A. M., Fernandes, R. F. E., & Pedro, L. M. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.08.080 · Cited by 100
Cardiovascular Aging and Longevity
Pietri, P. G., & Stefanadis, C. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.023 · Cited by 106
Ranzani, O., Kalra, A., Girolamo, C. D., Curto, A., Valério, F., Halonen, J. I., Basagaña, X., & Tonne, C. C. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004079 · Cited by 99
Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa
Akinyemi, R., Owolabi, M. O., Ihara, M., Damasceno, A. A. M., Ogunniyi, A. O., Dotchin, C. L., Paddick, S., Ogeng’o, J. A., Walker, R. W., & Kalaria, R. N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.018 · Cited by 101
Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018
Jafari‐Oori, M., Shahboulaghi, F. M., Nourozi, K., Fallahi‐Khoshknab, M., Ebadi, A., & Gheshlagh, R. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190118142818 · Cited by 98
Hypertension, Prehypertension, and Hypertension Control
de Menezes, S. T., Giatti, L., Brant, L. C. C., Griep, R. H., Schmidt, M. I., Duncan, B. B., Suemoto, C. K., Ribeiro, A. L. P., & Barreto, S. M. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16080 · Cited by 104
Xue, X., Deng, Y., Wang, J., Zhou, M., Liao, L., Wang, C., Peng, C. Y., & Li, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153694 · Cited by 105
Phenotyping the hypertensive heart
Tadić, M., Cuspidi, C., & Marwick, T. H. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac393 · Cited by 101
Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines
Hisamatsu, T., Segawa, H., Kadota, A., Ohkubo, T., Arima, H., & Miura, K. (2020) · Hypertension Research · doi:10.1038/s41440-020-0508-z · Cited by 102
Digital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 104
Ademe, S., Aga, F., & Gela, D. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-3880-0 · Cited by 108
Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health
Venditti, V., Bleve, E., Morano, S., & Filardi, T. (2023) · Metabolites · doi:10.3390/metabo13101087 · Cited by 118
DiPette, D. J., Skeete, J., Ridley, E., Campbell, N. R. C., López-Jaramillo, P. A., Kishore, S. P., Jaffe, M. G., Coca, A., Townsend, R. R., & Ordúñez, P. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13426 · Cited by 95
Kivuyo, S. L., Birungi, J., Okebe, J., Wang, D., Ramaiya, K. L., Ainan, S., Tumuhairwe, F., Ouma, S., Namakoola, I., Garrib, A. V., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01573-8 · Cited by 95
on behalf of the HOPE Asia Network, Park, S., Buranakitjaroen, P., Chen, C.-H., Chia, Y. C., Divinagracia, R. A., Hoshide, S., Shin, J., Siddique, S., Sison, J., et al. (2018) · Journal of Human Hypertension · doi:10.1038/s41371-017-0025-y · Cited by 94
Gumprecht, J. J., Domek, M., Lip, G. Y. H., & Shantsila, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0279-7 · Cited by 98
Liu, J., Bu, X., Wei, L., Wang, X., Lai, L., Dong, C., Ma, A., & Wang, T. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002958 · Cited by 100
“Also, men have a more unfavorable CVDs risk factor profile [32], and the disparities in behavioral and metabolic risk factors largely drive the sex difference in hypertension and CVDs [33].”
Tang, E., Ekundayo, O., Peipert, J. D., Edwards, N., Bansal, A., Richardson, C., Bartlett, S. J., Howell, D., Li, M., Cella, D. F., et al. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2058-2 · Cited by 95
Risk of hypertension into adulthood in persons born prematurely: A national cohort study
Crump, C., Sundquist, J., & Sundquist, K. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz904 · Cited by 93
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension
Juraschek, S. P., Hu, J., Cluett, J., Ishak, A. M., Mita, C., Lipsitz, L. A., Appel, L. J., Beckett, N. S., Coleman, R. L., Cushman, W. C., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-4298 · Cited by 98
Wang, Z., You, Y., Yin, Z., Bao, Q., Lei, S., Yu, J., Xie, C., Ye, F., & Xie, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.901225 · Cited by 95
Awareness, treatment, and control of hypertension and related factors in adult Iranian population
Mirzaei, M., Mirzaei, M., Bagheri-Fahraji, B., & Dehghani, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-08831-1 · Cited by 92
Dzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Bibliometric analysis of research relating to hypertension reported over the period 1997–2016
Devos, P., & Ménard, J. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002143 · Cited by 91
“Despite major therapeutic advances and public health efforts, the awareness, treatment and control of hypertension remain less than optimal, and vary between countries [3].”
BackgroundHossain, F. B., Shawon, M. S. R., Adhikary, G., & Chowdhury, A. (2019) · Clinical Hypertension · doi:10.1186/s40885-019-0134-8 · Cited by 101
Cowell, O. R., Mistry, N., Deighton, K., Matu, J., Griffiths, A., Minihane, A. M., Mathers, J. C., Shannon, O. M., & Siervo, M. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002667 · Cited by 96
“6 billion hypertensive individuals worldwide [4].”
Ghatage, T., Goyal, S., Dhar, A., & Bhat, A. (2021) · Hypertension Research · doi:10.1038/s41440-021-00643-z · Cited by 93
Filippini, T., Malavolti, M., Whelton, P. K., & Vinceti, M. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01182-9 · Cited by 96
Oxidative Stress in Kidney Injury and Hypertension
Arendshorst, W. J., Vendrov, A. E., Kumar, N., Ganesh, S. K., & Madamanchi, N. R. (2024) · Antioxidants · doi:10.3390/antiox13121454 · Cited by 108
Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK
Tapela, N. M., Collister, J. A., Clifton, L., Turnbull, I. J., Rahimi, K., & Hunter, D. J. (2021) · Open Heart · doi:10.1136/openhrt-2020-001461 · Cited by 90
Circadian regulation of renal function
Johnston, J. G., & Pollock, D. M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.018 · Cited by 91
Hypertension in Developing Countries: A Major Challenge for the Future
Ibrahim, M. M. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0839-1 · Cited by 98
Du, L., Cheng, Z., Zhang, Y., Li, Y., & Mei, D. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13272 · Cited by 88
Levit, A., Hachinski, V., & Whitehead, S. N. (2020) · GeroScience · doi:10.1007/s11357-020-00164-6 · Cited by 96
Mahdavi‐Roshan, M., Salari, A., Ghorbani, Z., & Ashouri, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102430 · Cited by 92
Parati, G., Lackland, D. T., Campbell, N. R. C., Owolabi, M. O., Bavuma, C. M., Beheiry, H., Dzudié, A., Ibrahim, M. M., Aroussy, W. A. E., Singh, S. K., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18884 · Cited by 90
Koya, S. F., Pilakkadavath, Z., Chandran, P., Wilson, T., Kuriakose, S., Akbar, S. K., & Ali, A. (2022) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2022.100113 · Cited by 87
Uchmanowicz, I., Markiewicz, K., Uchmanowicz, B., Kołtuniuk, A., & Rosińćzuk, J. (2019) · Clinical Interventions in Aging · doi:10.2147/cia.s188499 · Cited by 96
Hsu, C., & Tain, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228705 · Cited by 86
Stengel, B., Muenz, D. G., Tu, C., Speyer, É., de Pinho, N. A., Combe, C., Yamagata, K., Reichel, H., Fliser, D., Massy, Z. A., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.11.039 · Cited by 86
Ahmad, A., & Oparil, S. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08317 · Cited by 94
den Brok, M. G. H. E., van Dalen, J. W., Abdulrahman, H., Larson, E. B., van Middelaar, T., van Gool, W. A., Moll van Charante, E. P., & Richard, E. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.12.019 · Cited by 84
Neto, M. P. C., Aquino, J. D. S., da Silva, L. D. F. R., Silva, R. D. O., Guimarães, K. S. D. L., de Oliveira, Y., de Souza, E. L., Magnani, M., Vidal, H., & Alves, J. L. D. B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.020 · Cited by 84
Hasani, H., Arab, A., Hadi, A., Pourmasoumi, M., Ghavami, A., & Miraghajani, M. S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6362 · Cited by 84
“Hypertension, or high blood pressure (BP), is a global public health problem with an increasing incidence worldwide (Bahadoran, Mirmiran, Kabir, Azizi, & Ghasemi, 2017; Mills et al., 2016).”
BackgroundYi, X., Luo, H., Zhou, J., Yu, M., Chen, X., Tan, L., Wei, W., & Li, J. (2020) · BMC Neurology · doi:10.1186/s12883-019-1592-z · Cited by 84
Metadata
- Authors
- Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J.
- Affiliations
- Tulane University (US)
- ORCID
- Venue
- Circulation
- Published
- 2016-08-09
- Volume
- 134
- Issue
- 6
- Pages
- 441-450
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC4979614
- OpenAlex
- W2504981678
- Cited by
- 3,531
- References
- 39
- Citations by year
- 2026: 248 · 2025: 362 · 2024: 410 · 2023: 432 · 2022: 468 · 2021: 549 · 2020: 401 · 2019: 331 · 2018: 203 · 2017: 113 · 2016: 10
- FWCI
- 180.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- World Health Organization
- National Heart, Lung, and Blood Institute (U01HL114197, T32HL007024)
- National Institute of General Medical Sciences (P20GM109036)
- Fogarty International Center (D43TW009107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- hypertension, global health disparities, hypertension prevalence, hypertension awareness, antihypertensive therapy, blood pressure control, low- and middle-income countries, high-income countries, secular trends, global burden of disease
- MeSH terms
- Cross-Sectional Studies, Developing Countries, Humans, Hypertension, Population Surveillance, Global Health, Prevalence, Developed Countries, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
